Reply to: Medication contaminants as a potential cause of anaphylaxis to vincristine: What about drug specific antigens?
Pediatr Blood Cancer
.
2018 Feb;65(2):10.1002/pbc.26868.
doi: 10.1002/pbc.26868.
Epub 2017 Oct 19.
Authors
David A Hill
1
2
,
Allison Barz Leahy
3
,
Joseph Sciasci
4
,
Sean P O'Neill
5
,
Anne Reilly
3
,
Naomi Balamuth
3
,
Steven H Seeholzer
6
,
Jonathan M Spergel
1
2
,
Terri F Brown-Whitehorn
1
Affiliations
1
Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
2
Institute for Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
3
Division of Oncology.
4
Department of Pharmacy.
5
Office of Safety and Medical Operations.
6
Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
PMID:
29049863
PMCID:
PMC5739934
DOI:
10.1002/pbc.26868
No abstract available
Publication types
Letter
Comment
MeSH terms
Anaphylaxis*
Antigens
Drug Hypersensitivity*
Humans
Vincristine
Substances
Antigens
Vincristine
Grants and funding
T32 HD043021/HD/NICHD NIH HHS/United States